#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary optic atrophy Amyotrophic lateral sclerosis gene carrier Candida infection Oesophageal adenocarcinoma Immune-mediated renal disorder Corneal neovascularisation Anal cancer recurrent Asthma Alport's syndrome Basal cell naevus syndrome Diffuse large B-cell lymphoma Hypochondroplasia Metachromatic leukodystrophy Myasthenia gravis Progressive multifocal leukoencephalopathy More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Trials in Disease Pulmonary sarcoidosis – Life with Disease Haemolytic uraemic syndrome – Treatment Alternating hemiplegia of childhood – Basic Information Alport’s syndrome – Trials in Disease Tuberous sclerosis complex – Diagnostics Skin angiosarcoma – Life with Disease Systemic sclerosis pulmonary – Life with Disease Mucopolysaccharidosis III – Diagnostics Activated PI3 kinase delta syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bevacizumab SELTOREXANT ALKYLATING AGENTS L-PROLINE Ribonucleic Acid Pivekimab Sunirine Isis 678354 Sodium Salt Mifepristone Rifapentine Lactose Ozanimod Procarbazine Cldn6 Car-T Siponimod AZD4360 Vigabatrin [89ZR]ZR-DFO-CIT-013 Rupatadine Glyceryl Trinitrate Ly3541860 More therapies…

    Learn about Your Condition

    Diabetic autonomic neuropathy Alport's syndrome Diverticulitis Encephalopathy neonatal Melanoma recurrent Deafness Endometrial cancer metastatic Congenital pseudarthrosis Leukaemia Myotonic dystrophy Lymphocytic leukaemia Small cell lung cancer Radiation skin injury Meniere's disease Femur fracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Sodium Thiosulfate Injections for Patients with Ectopic Calcifications or Ossifications from Dermatomyositis, Systemic Sclerosis, or iPPSD2

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cutaneous calcification
    • Extraskeletal ossification
    • Vascular calcification
    Investigated Drugs:
    • Sodium Thiosulfate Pentahydrate
    France

  • Study Comparing Corticosteroid Injection and Arthrocentesis for Temporomandibular Joint Arthritis in Patients Using Methylprednisolone Acetate and Lidocaine Hydrochloride

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Lidocaine Hydrochloride
    • Methylprednisolone Acetate
    • Sodium Chloride
    Sweden

  • Study on Sufentanil’s Effect on Chronic Pain After Non-Major Abdominal Surgery for Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Sufentanil
    France

  • Study on Short vs. Long Antiplatelet Therapy with Aspirin for Adults After TAVI for Symptomatic Aortic Stenosis

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Aortic valve stenosis
    Investigated Drugs:
    • D,L-Lysine Acetylsalicylate
    • Acetylsalicylic Acid
    France

  • Study of V940 and Pembrolizumab for Patients with Resected Stage II, IIIA, IIIB Non-Small Cell Lung Cancer

    Recruiting

    3 1 1
    Investigated Drugs:
    • Mrna-4157
    • Pembrolizumab
    Belgium Czechia Denmark Estonia Finland France +12

  • Study on Reducing HIV-HBV Treatment with Darunavir, Ritonavir, and Lamivudine for Patients with Controlled Co-Infection

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Darunavir
    • Dolutegravir Sodium
    • Lamivudine
    France
Previous Page
1 … 453 454 455 456 457 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!